Stock Price Quote

INDO US BIO-TECH LTD.

NSE : INDOUSBSE : 541304ISIN CODE : INE250Z01010Industry : AgricultureHouse : Private
BSE156.302.8 (+1.82 %)
PREV CLOSE ( ) 153.50
OPEN PRICE ( ) 157.25
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1979
TODAY'S LOW / HIGH ( )153.45 158.20
52 WK LOW / HIGH ( )137.6 386
NSE156.680.52 (+0.33 %)
PREV CLOSE( ) 156.16
OPEN PRICE ( ) 157.80
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 156.68 (148)
VOLUME 8911
TODAY'S LOW / HIGH( ) 152.61 158.00
52 WK LOW / HIGH ( )138.13 388.4
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 04-02 2004
Management Info
- Chairman Jagdish Ajudia - Managing Director
Registered Office

Address 309, Shanti Mall, Satadhar Char Rasta,Opp. Navrang Tower,Sola Road ,
Ahmedabad,
Gujarat-380061

Phone 079 2749 1807 / 9909043999

Email indous_jagdish@yahoo.co.in

Website www.indousagriseeds.com

Registrars Details
Bigshare Services Pvt Ltd
Office No S6-2, 6th Floor, Pinnacle Business Park,Next to Ahura Centre, Mahakali Caves Road,Andheri (E),Mumbai
Listing : BSE, NSE

NEWS

10Jul Indo US Bio-Tech inks MoU with ICAR-IARI
Indo US Bio-Tech has signed Memorandum of Understanding (M0U) with ICAR-..
10Jul Indo US Bio-Tech jumps on inking MoU w
Indo US Bio-Tech is currently trading at Rs. 157.40, up by 3.90 points o..
26Jun Indo US Bio-Tech informs about disclos
With reference to the SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 date..
27May Indo Us Bio Tech informs about newspap
Indo Us Bio Tech has submitted the Newspaper Advertisement relating to A..
11Sep Indo US Bio-Tech informs about certifi
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..

Financials

in Millions
QTR Mar 25 ANNUAL 25
Net Profit36.85162.68
Gross Profit 38.79 165.31
Operating Profit 47.02191.17
Net Sales 333.851038.38

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Bombay Burmah Trdg. (BSE)
peergroup  1973.90 (1.28%)
M.Cap ( in Cr)13772.28
Hind Agrigenetics (BSE)
peergroup  95.50 (19.99%)
M.Cap ( in Cr)42.02
Apis India (BSE)
peergroup  324.55 (5.00%)
M.Cap ( in Cr)178.83
Naturite Agro Prod. (BSE)
peergroup  389.05 (1.99%)
M.Cap ( in Cr)206.04
Harrisons Malayalam (BSE)
peergroup  215.65 (1.70%)
M.Cap ( in Cr)397.99

Shareholding Pattern

PROMOTERS 70.17%
NON-INSTITUTION 29.83%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Indo US Bio-Tech Ltd.

Indo US Bio-Tech Ltd. was incorporated in the year 2004. Its today's share price is 156.3. Its current market capitalisation stands at Rs 313.41 Cr. In the latest quarter, company has reported Gross Sales of Rs. 728.36 Cr and Total Income of Rs.731.56 Cr. The company's management includes Ritaben Nileshbhai Kikani, Shilpa Thumar, Neha Patel, Priyanka Ajudia, Maltiben Ajudia, Jagdish Ajudia, Dimpy Joshi.

It is listed on the BSE with a BSE Code of 541304 , NSE with an NSE Symbol of INDOUS and ISIN of INE250Z01010. It's Registered office is at 309, Shanti Mall, Satadhar Char Rasta,Opp. Navrang Tower,Sola Road Ahmedabad-380061, Gujarat. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Bhagat & Associates, Gautam N Associates, Piyush J Shah & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.